Mangrove Partners IM LLC Purchases New Position in Chemed Corporation $CHE

Mangrove Partners IM LLC purchased a new stake in Chemed Corporation (NYSE:CHE) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 1,358 shares of the company’s stock, valued at approximately $581,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Los Angeles Capital Management LLC acquired a new position in Chemed in the fourth quarter valued at approximately $26,000. Smartleaf Asset Management LLC boosted its holdings in Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares in the last quarter. BOK Financial Private Wealth Inc. acquired a new position in Chemed in the fourth quarter valued at approximately $27,000. Global Retirement Partners LLC boosted its holdings in Chemed by 200.0% in the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after purchasing an additional 58 shares in the last quarter. Finally, Rothschild Investment LLC boosted its holdings in shares of Chemed by 800.0% in the fourth quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock valued at $46,000 after acquiring an additional 96 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CHE has been the subject of several research analyst reports. Royal Bank Of Canada increased their price objective on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Oppenheimer decreased their price objective on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Finally, Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Two equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $501.50.

Chemed Price Performance

Chemed stock opened at $432.70 on Wednesday. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $562.77. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The business has a 50 day simple moving average of $417.17 and a 200-day simple moving average of $424.24. The stock has a market capitalization of $5.74 billion, a PE ratio of 23.58, a price-to-earnings-growth ratio of 1.59 and a beta of 0.54.

Chemed (NYSE:CHE) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The business had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter in the prior year, the business earned $5.63 earnings per share. The company’s quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities analysts predict that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio is 13.08%.

Insider Activity at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director owned 4,578 shares in the company, valued at $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their position. The SEC filing for this sale provides additional information. 3.33% of the stock is owned by corporate insiders.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.